Skip to content
drillr.ai
Sign up

TERN

Terns Pharmaceuticals, Inc.

NASDAQ · Healthcare · Biotechnology · US

$52.95
−0.03%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue—————
Cost of Revenue—————
Gross Profit—————
Operating Expenses
R&D Expense77.9M77.9M70.1M63.5M39.6M
SG&A Expense32.2M32.2M31.8M39.1M22.4M
General & Admin Expense32.2M32.2M31.8M39.1M22.4M
Selling & Marketing Expense—————
Other Expenses—————
Total Operating Expenses110.1M110.1M101.9M102.6M62.0M
Cost and Expenses110.1M110.1M101.9M102.6M62.0M
Operating Income (EBIT)(110.1M)(110.1M)(101.9M)(102.6M)(62.0M)
Non-Operating
Interest Income14.6M14.6M13.3M12.9M2.1M
Interest Expense—————
Net Interest Income14.6M14.6M13.3M12.9M2.1M
Other Non-Op Income/Expense14.5M14.5M13.3M12.6M2.0M
Non-Operating Income (excl Interest)—————
EBT (Pre-Tax Income)(95.6M)(95.6M)(88.6M)(90.0M)(60.0M)
Income Tax Expense581.0K581.0K260.0K239.0K358.0K
Bottom Line
Net Income(96.2M)(96.2M)(88.9M)(90.2M)(60.3M)
Earnings from Cont. Ops(96.2M)(96.2M)(88.9M)(90.2M)(60.3M)
Earnings from Discont. Ops—————
Bottom Line Net Income(96.2M)(96.2M)(88.9M)(90.2M)(60.3M)
Per Share
Basic EPS($1.03)($1.03)($1.12)($1.27)($1.67)
Diluted EPS($1.03)($1.03)($1.12)($1.27)($1.67)
Revenue Per Share$0.00$0.00$0.00$0.00$0.00
Shares
Basic Shares Outstanding93.2M93.2M79.5M71.3M36.0M
Diluted Shares Outstanding93.2M93.2M79.5M71.3M36.0M
Profitability Metrics
EBITDA(110.1M)(110.1M)(101.0M)(101.7M)(61.0M)
D&A——896.0K881.0K1.0M
EBIT(110.1M)(110.1M)(101.9M)(102.6M)(62.0M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Dec 1, 2025